13395_2015_66_MOESM1_ESM.doc (35.5 kB)
Additional file 1: Table S1. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy
journal contribution
posted on 2015-12-10, 05:00 authored by Fernanda Pinto-Mariz, Luciana Rodrigues Carvalho, Alexandra Prufer De Queiroz Campos Araujo, Wallace De Mello, Mårcia Gonçalves Ribeiro, Maria Cunha, Pedro Cabello, Ingo Riederer, Elisa Negroni, Isabelle Desguerre, Mariana Veras, Erica Yada, Yves Allenbach, Olivier Benveniste, Thomas Voit, Vincent Mouly, Suse Silva-Barbosa, Gillian Butler-Browne, Wilson SavinoGeneral characteristics of the DMD patients enrolled in the study of blood samples. (DOC 35 kb)